Alzheimer’s Multi-Target Therapy
Tech ID
P27-1241
Patent Status
Granted in India
Design Status
--
Technical Description
The present invention provides N-(1- benzylpiperidin-4-yl)-5-(4-(trifluoromethyl) phenyl)-1,3,4-oxadiazol-2-amine as a multitargeted ligand to treat neurodegenerative disease.
Problems Addressed
- Aβ Accumulation in Brain
- Limitations of Existing Treatments
- Monofunctional Molecules
TARGET AUDIENCE
- Healthcare & Medical Sector
- Pharmaceutical Industry
- Biotechnology Firms
- Research and Development
TECH FEATURES
- Novel Compound
- Multitargeted Ligand
- Inhibits Cholinesterases & BACE-1
- No Toxic Reactions
- Enhanced BBB Permeability
- Low IC50 Value
- Anti-Aβ Aggregation Activity
P27-1241
Send download link to email.
Available For
Available for exclusive and non exclusive license
Sell off
Cost
—
Stage of Developments
Technology Validated
Contact Person
Mr. Lalit Ambastha
IP Bazzaar Technology Pvt. Ltd.
IP Bazzaar Technology Pvt. Ltd.
12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com